Finance

Lists
543245:BOM
Gland Pharma Ltd
3 043,50 INR
-0,45%
(-13,80) 1D
16-окт., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 543245...
Open
3 057,30 INR
High
3 061,25 INR
Low
3 005,10 INR
Mkt. cap
500,81 млд
Avg. vol.
434,88 миң
Volume
6,29 миң
Dividend
0,66%
Quarterly dividend
5,00 INR
Ex-dividend date
2026-ж., 11-авг.
P/E ratio
44,50
52-wk high
3 171,00 INR
52-wk low
1 575,00 INR
EPS
68,39 INR
No. of employees
4 миң
Open
3 057,30 INR
High
3 061,25 INR
Low
3 005,10 INR
Mkt. cap
500,81 млд
Avg. vol.
434,88 миң
Volume
6,29 миң
Dividend
0,66%
Quarterly dividend
5,00 INR
Ex-dividend date
2026-ж., 11-авг.
P/E ratio
44,50
52-wk high
3 171,00 INR
52-wk low
1 575,00 INR
EPS
68,39 INR
No. of employees
4 миң
News stories
From web sources and news partners
About Gland Pharma Ltd
CEOShyamakant Giri
Employees4,33 миң
Founded1978
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
14,87 млд
16,95 млд
17,43 млд
18,00 млд
Cost of goods sold
6,04 млд
6,31 млд
8,32 млд
6,80 млд
Cost of revenue
6,04 млд
6,31 млд
8,32 млд
6,80 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,85 млд
4,24 млд
4,26 млд
4,44 млд
Operating expense
6,75 млд
7,37 млд
5,22 млд
7,42 млд
Total operating expenses
12,79 млд
13,68 млд
13,54 млд
14,22 млд
Operating income
2,08 млд
3,27 млд
3,89 млд
3,78 млд
Other non operating income
841,62 млн
631,73 млн
-1,79 млд
612,28 млн
EBT including unusual items
2,84 млд
3,62 млд
5,06 млд
4,35 млд
EBT excluding unusual items
2,84 млд
3,86 млд
5,02 млд
4,35 млд
Income tax expense
1,00 млд
1,01 млд
1,39 млд
1,18 млд
Effective tax rate
35,30%
27,79%
27,51%
27,13%
Other operating expenses
1,84 млд
2,06 млд
-130,22 млн
1,87 млд
Net income
1,84 млд
2,61 млд
3,67 млд
3,17 млд
Net profit margin
12,35%
15,42%
21,04%
17,61%
Earnings per share
11,15
16,98
22,23
19,22
Interest and investment income
-
-
2,06 млд
-
Interest expense
-78,23 млн
-39,30 млн
-63,09 млн
-43,61 млн
Net interest expenses
-78,23 млн
-39,30 млн
1,99 млд
-43,61 млн
Depreciation and amortization charges
1,06 млд
1,08 млд
1,09 млд
1,11 млд
EBITDA
3,11 млд
4,17 млд
4,91 млд
4,80 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору